Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 9367069)

1.

Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.

Yim CY, Mao P, Spinella MJ.

AAPS J. 2014 Mar;16(2):281-8. doi: 10.1208/s12248-014-9562-2. Epub 2014 Jan 16. Review.

3.

The protective effect of amifostine on ultraviolet B-exposed xeroderma pigmentosum mice.

Henry S, Christiansen D, Kazmier F, Besch-Williford C, Concannon M.

Ecancermedicalscience. 2010;4:176. doi: 10.3332/ecancer.2010.176. Epub 2010 Sep 22.

4.

Reexamination of a meta-analysis of the effect of antioxidant supplementation on mortality and health in randomized trials.

Biesalski HK, Grune T, Tinz J, Zöllner I, Blumberg JB.

Nutrients. 2010 Sep;2(9):929-49. doi: 10.3390/nu2090929. Epub 2010 Aug 30.

5.

Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).

Kadakia KC, Barton DL, Loprinzi CL, Sloan JA, Otley CC, Diekmann BB, Novotny PJ, Alberts SR, Limburg PJ, Pittelkow MR.

Cancer. 2012 Apr 15;118(8):2128-37. doi: 10.1002/cncr.26374. Epub 2011 Aug 31.

6.

Supplement use and risk of cutaneous squamous cell carcinoma.

Asgari MM, Chren MM, Warton EM, Friedman GD, White E.

J Am Acad Dermatol. 2011 Dec;65(6):1145-51. doi: 10.1016/j.jaad.2010.09.009. Epub 2011 Jun 12.

7.

New agents for prevention of ultraviolet-induced nonmelanoma skin cancer.

Camp WL, Turnham JW, Athar M, Elmets CA.

Semin Cutan Med Surg. 2011 Mar;30(1):6-13. doi: 10.1016/j.sder.2011.01.003.

8.
9.

Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Amini S, Viera MH, Valins W, Berman B.

J Clin Aesthet Dermatol. 2010 Jun;3(6):20-34.

10.

A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.

Bailey HH, Kim K, Verma AK, Sielaff K, Larson PO, Snow S, Lenaghan T, Viner JL, Douglas J, Dreckschmidt NE, Hamielec M, Pomplun M, Sharata HH, Puchalsky D, Berg ER, Havighurst TC, Carbone PP.

Cancer Prev Res (Phila). 2010 Jan;3(1):35-47. doi: 10.1158/1940-6207.CAPR-09-0096.

11.

Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.

Tang JY, Aszterbaum M, Athar M, Barsanti F, Cappola C, Estevez N, Hebert J, Hwang J, Khaimskiy Y, Kim A, Lu Y, So PL, Tang X, Kohn MA, McCulloch CE, Kopelovich L, Bickers DR, Epstein EH Jr.

Cancer Prev Res (Phila). 2010 Jan;3(1):25-34. doi: 10.1158/1940-6207.CAPR-09-0200.

12.

Chemoprevention of human actinic keratoses by topical DL-alpha-tocopherol.

Foote JA, Ranger-Moore JR, Einspahr JG, Saboda K, Kenyon J, Warneke J, Miller RC, Goldman R, Xu MJ, Roe DJ, Alberts DS.

Cancer Prev Res (Phila). 2009 Apr;2(4):394-400. doi: 10.1158/1940-6207.CAPR-08-0210. Epub 2009 Mar 31.

13.

Tumor-suppressive activity of retinoic acid receptor-beta in cancer.

Xu XC.

Cancer Lett. 2007 Aug 8;253(1):14-24. Epub 2006 Dec 22. Review.

14.

Familiar drugs may prevent cancer.

Sharma RA, Gescher AJ, O'Byrne KJ, Steward WP.

Postgrad Med J. 2001 Aug;77(910):492-7. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk